Skip to content
Alterity Therapeutics

Alterity Therapeutics

ATH-434 is a small molecule that inhibits alpha synuclein pathology, designed to bind to pathological alpha-synuclein and prevent its toxic effects.

Cart 0

Your cart is currently empty.

Start Shopping